August 4, 2026

KKR to acquire Integer Holdings in $5.7bn all-cash deal

​Integer Holdings is to be acquired by an affiliate of investment funds managed by KKR, in an all-cash deal valuing...

August 4, 2026

Ascletis receives FDA clearance to begin Phase III ASC30 programme

​Ascletis Pharma has begun a global Phase III clinical programme for its once-daily oral small molecule GLP-1 receptor agonist, ASC30,...

August 4, 2026

Curium to acquire Lantheus in all-cash deal worth up to $8bn

​CapVest Partners-backed Curium has agreed to acquire rival US-based radiopharmaceutical company Lantheus in an all-cash deal worth up to nearly...

August 3, 2026

Moleculin reports interim results from MIRACLE trial in r/r AML patients

​Moleculin Biotech has reported preliminary blinded data from Part A of its ongoing pivotal Phase II/III MIRACLE trial assessing AnnAraC...

August 3, 2026

CereVasc expands manufacturing with Wilmington facility for eShunt System

​CereVasc has opened a new manufacturing and research facility in Wilmington, Massachusetts, as the company prepares for potential commercialisation of...

August 3, 2026

Ratio Therapeutics secures $70m Series C funding for cancer radiotherapy

​Ratio Therapeutics, a US-based developer of radiopharmaceuticals for cancer treatment, has closed a $70m Series C financing round.The post Ratio...

July 31, 2026

Median Technologies and Olea sign partnership for lung cancer device

​Median Technologies has partnered with Olea Medical to support the commercialisation of its eyonis LCS software in the US and...

July 31, 2026

Evommune begins Phase IIb trial of EVO756 for migraine

​Evommune has initiated a Phase IIb clinical trial of EVO756 for the prophylactic migraine treatment with the dosing of the...

July 31, 2026

Resilience and Lilly to increase US medicines production with $750m investment

​Resilience and Lilly have invested $750m to boost production of Lilly’s KwikPen to boost the US supply of diabetes and...

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.